CLDN 18.2 CAR-T cell therapy (Shanghai Longyao)
N/A
Report date: 2024/08/29 14:00:48
Base Information
Drug NameCLDN 18.2 CAR-T cell therapy (Shanghai Longyao)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Longyao Biological Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Longyao Biological Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A